封面
市場調查報告書
商品編碼
1530976

止血產品市場 - 2024-2034 年全球產業分析、規模、佔有率、成長、趨勢與預測

Hemostasis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

止血產品市場 - 報告範圍

TMR 關於全球止血產品市場的報告研究了過去以及當前的成長趨勢和機會,以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 ,考慮2024年為基準年,2034年為預測年。報告中也提供了2024年至2034年全球止血產品市場的年複合成長率(CAGR%)。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作,其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件,以了解止血產品市場。

市場概況
2023年市場價值 25億美元
2034 年市場價值 45 億美元
複合年成長率 5.7%

該報告深入研究了全球止血產品市場的競爭格局。全球止血產品市場的主要參與者已被確定,並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球止血產品市場參與者的屬性。

目錄

第1章:前言

第 2 章:假設與研究方法

第 3 章:執行摘要:全球市場

第 4 章:市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年全球市場分析與預測

第 5 章:關鍵見解

  • 按國家/地區分類的監管場景
  • 全球止血市場領導品牌
  • 重要產業事件(產品發布、重要併購等)
  • Covid-19 對產業的影響

第 6 章:全球市場分析與預測:依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測:按產品,2020-2034
    • 專題
      • 明膠
      • 多醣
      • 氧化再生纖維素
      • 膠原
    • 不熔的
      • 來自供體血液的濃縮血小板
      • 新鮮冷凍血漿 (FFP)
      • 因子VIII
      • 凝血酶原
    • 先進的
      • 可流動的
      • 凝血酶
      • 合成密封劑
      • 纖維蛋白
  • 市場吸引力分析:按產品

第 7 章:全球市場分析與預測:按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測:依應用分類,2020-2034
    • 創傷
    • 手術
    • 其他
  • 市場吸引力分析:按應用

第 8 章:全球市場分析與預測:按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測:按最終用戶,2020-2034
    • 醫院
    • 門診手術中心
    • 其他
  • 市場吸引力分析:按最終用戶

第 9 章:全球市場分析與預測:按地區

  • 主要發現
  • 市場價值預測:按地區,2020-2034
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析:按地區

第 10 章:北美市場分析與預測

第 11 章:歐洲市場分析與預測

第 12 章:亞太市場分析與預測

第 13 章:拉丁美洲市場分析與預測

第 14 章:中東和非洲市場分析與預測

第 15 章:競爭格局

  • 市場參與者 - 競爭矩陣(依公司層級和規模)
  • 公司市佔率分析 (2023)
  • 公司簡介
    • Pfizer, Inc.
    • Baxter International
    • Medtronic plc
    • Abbott
    • B. Braun Melsungen AG
    • Johnson & Johnson (Ethicon)
    • CSL
    • Becton, Dickinson, and Company
    • Precision Biologics
    • Sysmex Corporation
Product Code: TMRGL13880

Hemostasis Products Market - Scope of Report

TMR's report on the global hemostasis products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hemostasis products market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hemostasis products market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hemostasis products market.

Market Snapshot
Market Value in 2023US$ 2.5 Bn
Market Value in 2034US$ 4.5 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hemostasis products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hemostasis products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hemostasis products market.

The report delves into the competitive landscape of the global hemostasis products market. Key players operating in the global hemostasis products market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hemostasis products market profiled in this report.

Key Questions Answered in Global hemostasis products Market Report:

  • What is the sales/revenue generated by hemostasis products across all regions during the forecast period?
  • What are the opportunities in the global hemostasis products market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hemostasis Products Market - Research Objectives and Research Approach

The comprehensive report on the global hemostasis products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hemostasis products market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hemostasis products market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemostasis Products Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Hemostasis Products Market Analysis and Forecast, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by Country/Region
  • 5.2. Leading Brands in the Global Hemostasis Market
  • 5.3. Key Industry Events (Product Launch, Key Mergers and Acquisitions, etc.)
  • 5.4. Covid-19 Impact on Industry

6. Global Hemostasis Products Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2020-2034
    • 6.3.1. Topical Hemostasis Products
      • 6.3.1.1. Gelatin
      • 6.3.1.2. Polysaccharides
      • 6.3.1.3. Oxidized Regenerated Cellulose
      • 6.3.1.4. Collagen
    • 6.3.2. Infusible Hemostasis Products
      • 6.3.2.1. Platelet Concentrate from Donor Blood
      • 6.3.2.2. Fresh Frozen Plasma (FFP)
      • 6.3.2.3. Factor VIII
      • 6.3.2.4. Prothrombin
    • 6.3.3. Advanced Hemostasis Products
      • 6.3.3.1. Flowable
      • 6.3.3.2. Thrombin
      • 6.3.3.3. Synthetic Sealants
      • 6.3.3.4. Fibrin
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Hemostasis Products Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2034
    • 7.3.1. Trauma
    • 7.3.2. Surgery
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Hemostasis Products Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Hemostasis Products Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Hemostasis Products Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2020-2034
    • 10.2.1. Topical Hemostasis Products
      • 10.2.1.1. Gelatin
      • 10.2.1.2. Polysaccharides
      • 10.2.1.3. Oxidized Regenerated Cellulose
      • 10.2.1.4. Collagen
    • 10.2.2. Infusible Hemostasis Products
      • 10.2.2.1. Platelet Concentrate from Donor Blood
      • 10.2.2.2. Fresh Frozen Plasma (FFP)
      • 10.2.2.3. Factor VIII
      • 10.2.2.4. Prothrombin
    • 10.2.3. Advanced Hemostasis Products
      • 10.2.3.1. Flowable
      • 10.2.3.2. Thrombin
      • 10.2.3.3. Synthetic Sealants
      • 10.2.3.4. Fibrin
  • 10.3. Market Value Forecast, by Application, 2020-2034
    • 10.3.1. Surgery
    • 10.3.2. Trauma
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by End-user, 2020-2034
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgical Centers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Hemostasis Products Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2020-2034
    • 11.2.1. Topical Hemostasis Products
      • 11.2.1.1. Gelatin
      • 11.2.1.2. Polysaccharides
      • 11.2.1.3. Oxidized Regenerated Cellulose
      • 11.2.1.4. Collagen
    • 11.2.2. Infusible Hemostasis Products
      • 11.2.2.1. Platelet Concentrate from Donor Blood
      • 11.2.2.2. Fresh Frozen Plasma (FFP)
      • 11.2.2.3. Factor VIII
      • 11.2.2.4. Prothrombin
    • 11.2.3. Advanced Hemostasis Products
      • 11.2.3.1. Flowable
      • 11.2.3.2. Thrombin
      • 11.2.3.3. Synthetic Sealants
      • 11.2.3.4. Fibrin
  • 11.3. Market Value Forecast, by Application, 2020-2034
    • 11.3.1. Surgery
    • 11.3.2. Trauma
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by End-user, 2020-2034
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Hemostasis Products Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2020-2034
    • 12.2.1. Topical Hemostasis Products
      • 12.2.1.1. Gelatin
      • 12.2.1.2. Polysaccharides
      • 12.2.1.3. Oxidized Regenerated Cellulose
      • 12.2.1.4. Collagen
    • 12.2.2. Infusible Hemostasis Products
      • 12.2.2.1. Platelet Concentrate from Donor Blood
      • 12.2.2.2. Fresh Frozen Plasma (FFP)
      • 12.2.2.3. Factor VIII
      • 12.2.2.4. Prothrombin
    • 12.2.3. Advanced Hemostasis Products
      • 12.2.3.1. Flowable
      • 12.2.3.2. Thrombin
      • 12.2.3.3. Synthetic Sealants
      • 12.2.3.4. Fibrin
  • 12.3. Market Value Forecast, by Application, 2020-2034
    • 12.3.1. Surgery
    • 12.3.2. Trauma
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by End-user, 2020-2034
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgical Centers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Hemostasis Products Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2020-2034
    • 13.2.1. Topical Hemostasis Products
      • 13.2.1.1. Gelatin
      • 13.2.1.2. Polysaccharides
      • 13.2.1.3. Oxidized Regenerated Cellulose
      • 13.2.1.4. Collagen
    • 13.2.2. Infusible Hemostasis Products
      • 13.2.2.1. Platelet Concentrate from Donor Blood
      • 13.2.2.2. Fresh Frozen Plasma (FFP)
      • 13.2.2.3. Factor VIII
      • 13.2.2.4. Prothrombin
    • 13.2.3. Advanced Hemostasis Products
      • 13.2.3.1. Flowable
      • 13.2.3.2. Thrombin
      • 13.2.3.3. Synthetic Sealants
      • 13.2.3.4. Fibrin
  • 13.3. Market Value Forecast, by Application, 2020-2034
    • 13.3.1. Surgery
    • 13.3.2. Trauma
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by End-user, 2020-2034
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgical Centers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Hemostasis Products Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2020-2034
    • 14.2.1. Topical Hemostasis Products
      • 14.2.1.1. Gelatin
      • 14.2.1.2. Polysaccharides
      • 14.2.1.3. Oxidized Regenerated Cellulose
      • 14.2.1.4. Collagen
    • 14.2.2. Infusible Hemostasis Products
      • 14.2.2.1. Platelet Concentrate from Donor Blood
      • 14.2.2.2. Fresh Frozen Plasma (FFP)
      • 14.2.2.3. Factor VIII
      • 14.2.2.4. Prothrombin
    • 14.2.3. Advanced Hemostasis Products
      • 14.2.3.1. Flowable
      • 14.2.3.2. Thrombin
      • 14.2.3.3. Synthetic Sealants
      • 14.2.3.4. Fibrin
  • 14.3. Market Value Forecast, by Application, 2020-2034
    • 14.3.1. Surgery
    • 14.3.2. Trauma
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by End-user, 2020-2034
    • 14.4.1. Hospitals
    • 14.4.2. Ambulatory Surgical Centers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Pfizer, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Baxter International
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Medtronic plc
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Abbott
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. B. Braun Melsungen AG
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Johnson & Johnson (Ethicon)
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. CSL
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Becton, Dickinson, and Company
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Precision Biologics
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Sysmex Corporation
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Hemostasis Products Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 02: Global Hemostasis Products Market Value (US$ Mn) Forecast, by Topical Hemostasis Products, 2020-2034
  • Table 03: Global Hemostasis Products Market Value (US$ Mn) Forecast, by Infusible Hemostasis Products, 2020-2034
  • Table 04: Global Hemostasis Products Market Value (US$ Mn) Forecast, by Advanced Hemostasis Products, 2020-2034
  • Table 05: Global Hemostasis Products Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 06: Global Hemostasis Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 07: Global Hemostasis Products Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 08: North America Hemostasis Products Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 09: North America Hemostasis Products Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 10: North America Hemostasis Products Market Value (US$ Mn) Forecast, by Topical Hemostasis Products, 2020-2034
  • Table 11: North America Hemostasis Products Market Value (US$ Mn) Forecast, by Infusible Hemostasis Products, 2020-2034
  • Table 12: North America Hemostasis Products Market Value (US$ Mn) Forecast, by Advanced Hemostasis Products, 2020-2034
  • Table 13: North America Hemostasis Products Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 14: North America Hemostasis Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 15: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 16: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 17: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by Topical Hemostasis Products, 2020-2034
  • Table 18: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by Infusible Hemostasis Products, 2020-2034
  • Table 19: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by Advanced Hemostasis Products, 2020-2034
  • Table 20: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 21: Europe Hemostasis Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 22: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 23: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 24: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by Topical Hemostasis Products, 2020-2034
  • Table 25: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by Infusible Hemostasis Products, 2020-2034
  • Table 26: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by Advanced Hemostasis Products, 2020-2034
  • Table 27: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 28: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 29: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 30: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 31: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by Topical Hemostasis Products, 2020-2034
  • Table 32: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by Infusible Hemostasis Products, 2020-2034
  • Table 33: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by Advanced Hemostasis Products, 2020-2034
  • Table 34: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 35: Latin America Hemostasis Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 36: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 37: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 38: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by Topical Hemostasis Products, 2020-2034
  • Table 39: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by Infusible Hemostasis Products, 2020-2034
  • Table 40: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by Advanced Hemostasis Products, 2020-2034
  • Table 41: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 42: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Hemostasis Products Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Hemostasis Products Market Value Share, by Product, 2023
  • Figure 03: Global Hemostasis Products Market Value Share, by Application, 2023
  • Figure 04: Global Hemostasis Products Market Value Share, by End-User, 2023
  • Figure 05: Global Hemostasis Products Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 06: Global Hemostasis Products Market Share Analysis, by Product, 2023
  • Figure 07: Global Hemostasis Products Market Share Analysis, by Product, 2034
  • Figure 08: Global Hemostasis Products Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 09: Global Hemostasis Products Market Value (US$ Mn), by Topical Hemostasis Products, 2020-2034
  • Figure 10: Global Hemostasis Products Market Value Share Analysis, by Topical Hemostasis Products, 2023 and 2034
  • Figure 11: Global Hemostasis Products Market Value (US$ Mn), by Infusible Hemostasis Products, 2020-2034
  • Figure 12: Global Hemostasis Products Market Value Share Analysis, by Infusible Hemostasis Products, 2023 and 2034
  • Figure 13: Global Hemostasis Products Market Value (US$ Mn), by Advanced Hemostasis Products, 2020-2034
  • Figure 14: Global Hemostasis Products Market Value Share Analysis, by Advanced Hemostasis Products, 2023 and 2034
  • Figure 15: Global Hemostasis Products Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 16: Global Hemostasis Products Market Share Analysis, by Application, 2023
  • Figure 17: Global Hemostasis Products Market Share Analysis, by Application, 2034
  • Figure 18: Global Hemostasis Products Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 19: Global Hemostasis Products Market Value (US$ Mn), by Surgery, 2020-2034
  • Figure 20: Global Hemostasis Products Market Value Share Analysis, by Surgery, 2023 and 2034
  • Figure 21: Global Hemostasis Products Market Value (US$ Mn), by Trauma, 2020-2034
  • Figure 22: Global Hemostasis Products Market Value Share Analysis, by Trauma, 2023 and 2034
  • Figure 23: Global Hemostasis Products Market Value (US$ Mn), by Others, 2020-2034
  • Figure 24: Global Hemostasis Products Market Value Share Analysis, by Colorectal Surgery, 2023 and 2034
  • Figure 25: Global Hemostasis Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 26: Global Hemostasis Products Market Share Analysis, by End-user, 2023
  • Figure 27: Global Hemostasis Products Market Share Analysis, by End-user, 2034
  • Figure 28: Global Hemostasis Products Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 29: Global Hemostasis Products Market Value (US$ Mn), by Hospitals, 2020-2034
  • Figure 30: Global Hemostasis Products Market Value Share Analysis, by Hospitals, 2023 and 2034
  • Figure 31: Global Hemostasis Products Market Value (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
  • Figure 32: Global Hemostasis Products Market Value Share Analysis, by Ambulatory Surgical Centers, 2023 and 2034
  • Figure 33: Global Hemostasis Products Market Value (US$ Mn), by Others 2020-2034
  • Figure 34: Global Hemostasis Products Market Value Share Analysis, by Others 2023 and 2034
  • Figure 35: Global Hemostasis Products Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Hemostasis Products Market Share Analysis, by Region, 2023
  • Figure 37: Global Hemostasis Products Market Share Analysis, by Region, 2034
  • Figure 38: Global Hemostasis Products Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 39: North America Hemostasis Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Hemostasis Products Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Hemostasis Products Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Hemostasis Products Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 43: North America Hemostasis Products Market Share Analysis, by Product, 2023
  • Figure 44: North America Hemostasis Products Market Share Analysis, by Product, 2034
  • Figure 45: North America Hemostasis Products Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 46: North America Hemostasis Products Market Share Analysis, by Application, 2023
  • Figure 47: North America Hemostasis Products Market Share Analysis, by Application, 2034
  • Figure 48: North America Hemostasis Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 49: North America Hemostasis Products Market Share Analysis, by End-user, 2023
  • Figure 50: North America Hemostasis Products Market Share Analysis, by End-user, 2034
  • Figure 51: Europe Hemostasis Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 52: Europe Hemostasis Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 53: Europe Hemostasis Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 54: Europe Hemostasis Products Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 55: Europe Hemostasis Products Market Share Analysis, by Product, 2023
  • Figure 56: Europe Hemostasis Products Market Share Analysis, by Product, 2034
  • Figure 57: Europe Hemostasis Products Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 58: Europe Hemostasis Products Market Share Analysis, by Application, 2023
  • Figure 59: Europe Hemostasis Products Market Share Analysis, by Application, 2034
  • Figure 60: Europe Hemostasis Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 61: Europe Hemostasis Products Market Share Analysis, by End-user, 2023
  • Figure 62: Europe Hemostasis Products Market Share Analysis, by End-user, 2034
  • Figure 63: Asia Pacific Hemostasis Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 64: Asia Pacific Hemostasis Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 65: Asia Pacific Hemostasis Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 66: Asia Pacific Hemostasis Products Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 67: Asia Pacific Hemostasis Products Market Share Analysis, by Product, 2023
  • Figure 68: Asia Pacific Hemostasis Products Market Share Analysis, by Product, 2034
  • Figure 69: Asia Pacific Hemostasis Products Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 70: Asia Pacific Hemostasis Products Market Share Analysis, by Application, 2023
  • Figure 71: Asia Pacific Hemostasis Products Market Share Analysis, by Application, 2034
  • Figure 72: Asia Pacific Hemostasis Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Asia Pacific Hemostasis Products Market Share Analysis, by End-user, 2023
  • Figure 74: Asia Pacific Hemostasis Products Market Share Analysis, by End-user, 2034
  • Figure 75: Latin America Hemostasis Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 76: Latin America Hemostasis Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 77: Latin America Hemostasis Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 78: Latin America Hemostasis Products Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 79: Latin America Hemostasis Products Market Share Analysis, by Product, 2023
  • Figure 80: Latin America Hemostasis Products Market Share Analysis, by Product, 2034
  • Figure 81: Latin America Hemostasis Products Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 82: Latin America Hemostasis Products Market Share Analysis, by Application, 2023
  • Figure 83: Latin America Hemostasis Products Market Share Analysis, by Application, 2034
  • Figure 84: Latin America Hemostasis Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 85: Latin America Hemostasis Products Market Share Analysis, by End-user, 2023
  • Figure 86: Latin America Hemostasis Products Market Share Analysis, by End-user, 2034
  • Figure 87: Middle East and Africa Hemostasis Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 88: Middle East & Africa Hemostasis Products Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 89: Middle East & Africa Hemostasis Products Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 90: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 91: Middle East & Africa Hemostasis Products Market Share Analysis, by Product, 2023
  • Figure 92: Middle East & Africa Hemostasis Products Market Share Analysis, by Product, 2034
  • Figure 93: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 94: Middle East & Africa Hemostasis Products Market Share Analysis, by Application, 2023
  • Figure 95: Middle East & Africa Hemostasis Products Market Share Analysis, by Application, 2034
  • Figure 96: Middle East & Africa Hemostasis Products Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 97: Middle East & Africa Hemostasis Products Market Share Analysis, by End-user, 2023
  • Figure 98: Middle East & Africa Hemostasis Products Market Share Analysis, by End-user, 2034